IRCT20221130056672N1Not yet recruitingPhase 1
Investigating the Safety and Efficacy of Umbilical Cord Blood Serum Derived Extracellular Vesicles versus Autologus Platelet Rich Plasma and Minoxidil for Treatment of Androgenic Alopecia
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •Women and men with hereditary hormonal hair loss
- •Age 18 years and above and less than 50 years
- •The rate of hair loss in patients is Hamilton score 2 to 5 in men and Ludwig score 1 to 3 in women.
- •Complete consent of the patient to participate in the study
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 2
Evaluate efficacy and safety of umbilical cord-derived mesenchymal stromal cells (HLC-001) for patient with Noninfectious lung complications after allogeneic haematopoietic stem cell transplantatioJPRN-jRCT2063220014Morio Ikeda12
Recruiting
Phase 1
Safety and efficacy evaluation of human Mesenchymal Stem Cells (MSCs) in patients with SARS-CoV-2 infectioCTRI/2021/09/036645ifeCell International Pvt Ltd
Not yet recruiting
Phase 1
Stem cells following haemorrhagic or ischaemic fetal stroke (STELLAR)Fetal strokeStroke - HaemorrhagicStroke - IschaemicReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12622000662763Monash Health6
Recruiting
Phase 1
Safety and efficacy of umbilical cord-derived mesenchymal stem cells treatment for patients with Critical Limb IschemiaCritical Limb Ischemia.Critical Limb IschemiaG173.9IRCT20211021052828N2Rasht University of Medical Sciences5
Recruiting
Phase 1
Safety and efficacy of injection of Umbilical Cord Blood Serum derived exosomes for skin lesions in patients with chronic psoriasisIRCT20221130056672N4Tehran University of Medical Sciences30